1,062,105 Shares in Quanterix Co. (NASDAQ:QTRX) Acquired by William Blair Investment Management LLC

William Blair Investment Management LLC purchased a new stake in shares of Quanterix Co. (NASDAQ:QTRX - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,062,105 shares of the company's stock, valued at approximately $11,290,000. William Blair Investment Management LLC owned 2.76% of Quanterix as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Moors & Cabot Inc. lifted its stake in Quanterix by 107.5% in the fourth quarter. Moors & Cabot Inc. now owns 30,873 shares of the company's stock valued at $328,000 after buying an additional 15,992 shares during the period. Raymond James Financial Inc. acquired a new position in Quanterix in the fourth quarter valued at about $570,000. Levin Capital Strategies L.P. acquired a new position in Quanterix in the fourth quarter valued at about $159,000. Bank of New York Mellon Corp lifted its stake in Quanterix by 1.8% in the fourth quarter. Bank of New York Mellon Corp now owns 108,186 shares of the company's stock valued at $1,150,000 after buying an additional 1,963 shares during the period. Finally, Valmark Advisers Inc. lifted its stake in Quanterix by 88.3% in the fourth quarter. Valmark Advisers Inc. now owns 210,878 shares of the company's stock valued at $2,242,000 after buying an additional 98,883 shares during the period. Institutional investors and hedge funds own 86.48% of the company's stock.

Analyst Ratings Changes

Separately, Canaccord Genuity Group dropped their price target on Quanterix from $20.00 to $15.00 and set a "buy" rating on the stock in a research report on Tuesday.

Remove Ads

Quanterix Stock Down 0.3 %

Shares of NASDAQ:QTRX traded down $0.02 during mid-day trading on Friday, reaching $7.22. 705,141 shares of the stock were exchanged, compared to its average volume of 506,833. The company has a market cap of $278.14 million, a P/E ratio of -6.81 and a beta of 1.34. Quanterix Co. has a one year low of $6.30 and a one year high of $24.87. The stock's 50 day simple moving average is $8.18 and its 200-day simple moving average is $10.84.

Quanterix (NASDAQ:QTRX - Get Free Report) last posted its quarterly earnings data on Monday, March 17th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.27) by ($0.03). The firm had revenue of $35.16 million for the quarter, compared to the consensus estimate of $34.93 million. Quanterix had a negative return on equity of 11.74% and a negative net margin of 30.12%. Analysts anticipate that Quanterix Co. will post -0.98 EPS for the current fiscal year.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.